Review



two-way anova followed by a post hoc bonferroni test graphpad prism 8.4.2  (GraphPad Software Inc)


Bioz Verified Symbol GraphPad Software Inc is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    GraphPad Software Inc two-way anova followed by a post hoc bonferroni test graphpad prism 8.4.2
    Two Way Anova Followed By A Post Hoc Bonferroni Test Graphpad Prism 8.4.2, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/bonferroni+post+hoc+test+graphpad+prism+8%2E4%2E2/pm34547401-75-5-14?v=GraphPad+Software+Inc
    Average 90 stars, based on 1 article reviews
    two-way anova followed by a post hoc bonferroni test graphpad prism 8.4.2 - by Bioz Stars, 2026-08
    90/100 stars

    Images



    Similar Products

    90
    GraphPad Software Inc two-way anova followed by a post hoc bonferroni test graphpad prism 8.4.2
    Two Way Anova Followed By A Post Hoc Bonferroni Test Graphpad Prism 8.4.2, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/bonferroni+post+hoc+test+graphpad+prism+8%2E4%2E2/pm34547401-75-5-14?v=GraphPad+Software+Inc
    Average 90 stars, based on 1 article reviews
    two-way anova followed by a post hoc bonferroni test graphpad prism 8.4.2 - by Bioz Stars, 2026-08
    90/100 stars
      Buy from Supplier

    90
    GraphPad Software Inc bonferroni post hoc test graphpad prism 8.4.2
    Active CD is associated with mitochondrial ultrastructural abnormalities in enterocytes and goblet cells. ( A , B ) Representative TEM image of enterocytes ( A ) and goblet cells ( B ). Yellow star denotes normal mitochondria, red star mitochondria with ultrastructural abnormality. Scale bars: 2 μm, boxed pullout: 1 μm. ( C ) Quantitation of mitochondria with ultrastructural abnormalities. Results are presented as individual data points ± SEM of 30 inactive and 19 active CD patients. **** p < 0.001 by one-way ANOVA and <t>Bonferroni</t> post hoc test ( C ).
    Bonferroni Post Hoc Test Graphpad Prism 8.4.2, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/bonferroni+post+hoc+test+graphpad+prism+8%2E4%2E2/pmc08226558-148-13-17?v=GraphPad+Software+Inc
    Average 90 stars, based on 1 article reviews
    bonferroni post hoc test graphpad prism 8.4.2 - by Bioz Stars, 2026-08
    90/100 stars
      Buy from Supplier

    Image Search Results


    Active CD is associated with mitochondrial ultrastructural abnormalities in enterocytes and goblet cells. ( A , B ) Representative TEM image of enterocytes ( A ) and goblet cells ( B ). Yellow star denotes normal mitochondria, red star mitochondria with ultrastructural abnormality. Scale bars: 2 μm, boxed pullout: 1 μm. ( C ) Quantitation of mitochondria with ultrastructural abnormalities. Results are presented as individual data points ± SEM of 30 inactive and 19 active CD patients. **** p < 0.001 by one-way ANOVA and Bonferroni post hoc test ( C ).

    Journal: Cells

    Article Title: Targeting Mitochondrial Damage as a Therapeutic for Ileal Crohn’s Disease

    doi: 10.3390/cells10061349

    Figure Lengend Snippet: Active CD is associated with mitochondrial ultrastructural abnormalities in enterocytes and goblet cells. ( A , B ) Representative TEM image of enterocytes ( A ) and goblet cells ( B ). Yellow star denotes normal mitochondria, red star mitochondria with ultrastructural abnormality. Scale bars: 2 μm, boxed pullout: 1 μm. ( C ) Quantitation of mitochondria with ultrastructural abnormalities. Results are presented as individual data points ± SEM of 30 inactive and 19 active CD patients. **** p < 0.001 by one-way ANOVA and Bonferroni post hoc test ( C ).

    Article Snippet: Multiple comparisons were conducted with either one-way or two-way ANOVA followed by a Bonferroni post hoc test (GraphPad Prism 8.4.2, San Diego, CA, USA).

    Techniques: Quantitation Assay